Cassady Schiller Wealth Management, LLC Agios Pharmaceuticals, Inc. Transaction History
Cassady Schiller Wealth Management, LLC
- $268 Million
- Q4 2024
A detailed history of Cassady Schiller Wealth Management, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Cassady Schiller Wealth Management, LLC holds 15 shares of AGIO stock, worth $509. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15Holding current value
$509% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AGIO
# of Institutions
240Shares Held
58.4MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$192 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$191 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$165 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$127 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$96.2 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.86B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...